Ruben A. Mesa, MD

Today I join >600 Physicians & Scientists & thousands of team members of @WakeCancer & @LevineCancer joined as one @theNCI Comprehensive Cancer Center - world class cancer care, research & training decreasing cancer burden in the Carolinas & beyond @AtriumHealth @AtriumHealthWFB

World-Class Cancer Care Through Multidisciplinary Programs and Precision Medicine - Ruben Mesa @mpdrc oncodaily.com/voices/ruben-m…

Inspired by the Impact of Advocate Good Shepherd Hospital - Ruben Mesa @mpdrc oncodaily.com/voices/ruben-m…

The ASH Committee on Communications just finished a productive Summer 2026 meeting! Members discussed the continued work of #Fight4Hematology and more. Thanks to all committee members for their dedication to advancing the field.

@LeonidasPlatan1 Few things beat the summer in Chicago, especially along the lake!

Chicago

Ruben Mesa, MD Mesa Highlights Key Updates From the 2026 National Cancer Update Conference @mpdrc oncodaily.com/voices/ruben-m…

Bringing “The Best of Who We Are, to Where You Are” in Cancer Care - Ruben Mesa (@mpdrc) oncodaily.com/voices/ruben-m…

@PharmaEssentia Great picture! Greetings to my friends at @PharmaEssentia , congratulations on your success in benefitting #MPN patients

Our people drive everything we do at PharmaEssentia. Proud to foster a culture built on collaboration, purpose, and innovation as we continue advancing care for patients worldwide.

New Greensboro Campus Brings World-Class Cancer Care Closer to Home - Ruben Mesa @mpdrc @AtriumHealthWFB oncodaily.com/voices/ruben-m…

I’m excited to see the launch of the @NIH Office of Research Innovation, Validation, and Application. At @theNCI, we see tremendous potential in human-based research technologies to improve translation, accelerate discovery, and better serve patients. ➡️ go.nih.gov/G8kR74G

Huge congratulations to @LeonMizrachi our @wakeforestmed #Chair #CancerMedicine for being awarded the @ASH_hematology 2026 Roland B. Scott-Charles Drew Excellence in Equity Award!! Well deserved Leon for your #mentorship #education and #research leadership @LevineCancer

✨ #EHA2026 in Stockholm brought together global experts in hematology to share the latest developments shaping clinical practice. Non-malignant hematology took center stage, with important updates in thrombosis, hemostasis, sickle cell disease, hemophilia and rare bleeding disorders. From gene editing and clinical trials to real-world insights, these perspectives capture the science, discussion and momentum driving the field forward. 👇 Explore the key posts: hemostasistoday.com/blog/eha-2026-… @EHA_Hematology | @miesbach | @mpdrc | @HeghinKhach2025 #HemostasisToday

CONGRESS | #EHA2026 | POSTER Harry Gill presents integrated safety and efficacy data from the phase III SURPASS-ET and phase IIb EXCEED-ET studies, evaluating ropeginterferon alfa-2b in #EssentialThrombocythemia (ropeginterferon alfa-2b, n = 182; anagrelide, n = 83). - In SURPASS-ET, ropeginterferon alfa-2b treatment resulted in higher durable modified objective ELN response at Months 9 and 12 vs anagrelide (58.0% vs 19.5%; p < 0.0001). - In EXCEED-ET, durable modified objective ELN responses of up to 60.2% were observed at Months 10 and 13. - Comparable safety was observed across the two studies; the most frequent TEAEs were increased ALT and AST (45.1% each), anemia (29.1%), headache (25.8%), and decreased WBC (23.1%). Follow our live feed for more updates: loom.ly/N2uNnTk Intended for HCPs only. This congress coverage is independently supported by pharmaceutical companies, who are allowed no influence on the content; a full list of supporters can be found on our website. #MPN #MPNsm #MedicalCongress @HarryGillHKUMed @hkumed

As #EHA2026 comes to an end taking a moment to congratulate amazing friend, #MPNcolleague, world class investigator, mentor, educator @harrisoncn1 on the @EHA_Hematology lifetime achievement award! Congrats Claire on award & #AwardTalk model of teamwork that is #clinicalresearch

👏👏👏Outstanding MPN oral session at #EHA26 #EHA2026 !!!!! With our growing global 🌍 #MPNSM community of researchers! #JAK2 #CALR #MPL #KIT #hepcidin | @mpdrc @harrisoncn1 @SKordasti @KordastiL @beth_psaila @pankitvachhani @AdamMead_Oxford

👉#EHA26 #EH2026 | Important oral presentation by Prof F Passamonti 🇮🇹 to kick off MPN oral session @EHA_Hematology | ph3 #Independence results #Luspatercept for patients with Myelofibrosis | #MPNSM

Celebrating Claire Harrison’s EHA Lifetime Achievement Award - Ruben Mesa (@mpdrc) @EHA_Hematology oncodaily.com/voices/ruben-m…

Good to see you all @mpdrc @Dr_AmerZeidan @tariqkewan . #EHA2026

@KellyMezaMD Great to see you, and introduce you to my good friend @LeonMizrachi

It's always nice to see Dr. Meza @mpdrc a great mentor and role model #EHA2026